Abstract:Background: Hepatocellular carcinoma (HCC) is the fifth most common tumor worldwide. Because many hepatocellular carcinomas are already unresectable at the time of initial diagnosis, percutaneous tumor ablation has become established in recent decades as a curative therapeutic approach for very early (BCLC 0) and early (BCLC A) HCC. The aim of this paper is to provide a concise overview of the percutaneous local ablative procedures currently in use, based on their technical characteristics as well as clinical relevance, taking into account the current body of studies. Materials and methods: The literature search included all original papers, reviews, and meta-analyses available via MEDLINE and Pubmed on the respective percutaneous ablation procedures; the primary focus was on randomized controlled trials and publications from the last 10 years. Results and conclusions: Radiofrequency ablation (RFA) and microwave ablation (MWA) are well-established procedures that are considered equal to surgical resection in the treatment of stage BCLC 0 and A HCC with a diameter up to 3 cm due to their strong evidence in international and national guidelines. For tumors with a diameter between 3 and 5 cm, the current S3 guidelines recommend a combination of transarterial chemoembolization (TACE) and thermal ablation using RFA or MWA as combination therapy is superior to thermal ablation alone in tumors of this size and shows comparable results to surgical resection in terms of overall survival. Alternative, less frequently employed thermal procedures include cryotherapy (CT) and laser ablation (LA). Non-thermal procedures include irreversible electroporation (IRE), interstitial brachytherapy (IBT), and most recently, electrochemotherapy (ECT). Due to insufficient evidence, these have only been used in individual cases and within the framework of studies. However, the nonthermal methods are a reasonable alternative for ablation of tumors adjacent to large blood vessels and bile ducts because they cause significantly less damage to these structures than thermal ablation methods. With advances in the technology of the respective procedures, increasingly good evidence, and advancements in supportive techniques such as navigation devices and fusion imaging, percutaneous ablation procedures may expand their indications for the treatment of larger and more advanced tumors in the coming years. Key points: · RFA and MWA are considered equal to surgical resection as a first-line therapy for the curative treatment of stage BCLC 0 and A HCCs with a diameter of up to 3 cm.. · For HCCs with a diameter between 3 and 5 cm, a combination of TACE and RFA or MWA is recommended. This combination therapy yields results comparable to those of surgical resection in terms of overall survival.. · Due to insufficient evidence, alternative ablation methods have only been used in individual cases and within the framework of studies. However, nonthermal methods, such as IRE, IBT, and, most recently, ECT, are a reasonable alternative for ablation of HCCs adjacent to large blood vessels and bile ducts because they cause significantly less damage to these structures than thermal ablation methods.. Citation format: · Luerken L, Haimerl M, Doppler M et al. Update on Percutaneous Local Ablative Procedures for the Treatment of Hepatocellular Carcinoma. Fortschr Röntgenstr 2022; 194: 1075 - 1086.

Technique efficacy and complications after ablation as first surgical intervention for hepatocellular carcinoma: A nationwide database study

Laparoscopic ablation for liver malignancies: initial experience at a Scandinavian high volume HPB center

Outcomes and Complications of Image-Guided Percutaneous Tumour Ablation for Hepatocellular Carcinoma at the Irish National Liver Transplant Centre

Survival of Patients Receiving Radiofrequency Ablation or Ethanol Injection for Early-Stage Hepatocellular Carcinoma.

Laparoscopic Microwave Ablation of Hepatocellular Carcinoma at Liver Surface: Technique Effectiveness and Long-Term Outcomes.

Risk factors of complications after thermal ablation for hepatocellular carcinoma: the role of assessment of liver background

[Efficacy of Radiofrequency Ablation of 343 Patients with Hepatic Tumor and the Relevant Complications].

Comparison Of Long-Term Effectiveness And Complications Of Radiofrequency Ablation With Hepatectomy For Small Hepatocellular Carcinoma

Evaluation of the effectiveness of surgical resection and ablation for the treatment of early-stage hepatocellular carcinoma: A retrospective cohort study

Treatment Efficacy of Radiofrequency Ablation of 338 Patients with Hepatic Malignant Tumor and the Relevant Complications.

Update on Percutaneous Local Ablative Procedures for the Treatment of Hepatocellular Carcinoma

Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment

Initial Incomplete Thermal Ablation Is Associated With a High Risk of Tumor Progression in Patients With Hepatocellular Carcinoma

Efficiency and Safety of Radiofrequency-Assisted Hepatectomy for Hepatocellular Carcinoma with Cirrhosis: A Single-Center Retrospective Cohort Study

Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes.

Comparison of short- and long-term outcomes of patients with hepatocellular carcinoma undergoing surgical resection, local ablation, angiological treatment or palliation: Single center results over 35 years

Percutaneous Thermal Ablation for the Treatment of Colorectal Liver Metastases and Hepatocellular Carcinoma: a Comparison of Local Therapeutic Efficacy

Major Complications after Radiofrequency Ablation for Liver Tumors: Analysis of 255 Patients.

Clinical Short—term Results of Radiofrequency Ablation in L;iver Cancers

Long‐term efficacy of no‐touch radiofrequency ablation in the treatment of single small hepatocellular carcinoma: A single center long‐term follow‐up study

Feasibility and Outcomes of Percutaneous Radiofrequency Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma after Liver Transplantation: a Single-Center Experience